[go: up one dir, main page]

DK0831820T3 - Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform - Google Patents

Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform

Info

Publication number
DK0831820T3
DK0831820T3 DK96913862T DK96913862T DK0831820T3 DK 0831820 T3 DK0831820 T3 DK 0831820T3 DK 96913862 T DK96913862 T DK 96913862T DK 96913862 T DK96913862 T DK 96913862T DK 0831820 T3 DK0831820 T3 DK 0831820T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
oral pharmaceutical
solution form
piperidinoalkanol compounds
piperidinoalkanol
Prior art date
Application number
DK96913862T
Other languages
Danish (da)
English (en)
Inventor
Thomas T Ortyl
Paul F Skultety
Gail H Hurst
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0831820T3 publication Critical patent/DK0831820T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DK96913862T 1995-06-06 1996-04-30 Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform DK0831820T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,392 US5574045A (en) 1995-06-06 1995-06-06 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
PCT/US1996/005968 WO1996039139A1 (fr) 1995-06-06 1996-04-30 Composition pharmaceutique orale de composes de piperidinoalcanol sous forme de solutions

Publications (1)

Publication Number Publication Date
DK0831820T3 true DK0831820T3 (da) 2004-04-13

Family

ID=23863607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96913862T DK0831820T3 (da) 1995-06-06 1996-04-30 Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform

Country Status (22)

Country Link
US (1) US5574045A (fr)
EP (1) EP0831820B1 (fr)
JP (1) JP4091655B2 (fr)
KR (1) KR100509316B1 (fr)
CN (1) CN1139386C (fr)
AR (1) AR002191A1 (fr)
AT (1) ATE256465T1 (fr)
AU (1) AU707218B2 (fr)
CA (1) CA2218643C (fr)
DE (1) DE69631132T2 (fr)
DK (1) DK0831820T3 (fr)
ES (1) ES2211954T3 (fr)
HU (1) HU227710B1 (fr)
IL (1) IL118525A (fr)
MX (1) MX9709453A (fr)
NO (1) NO318029B1 (fr)
NZ (1) NZ307370A (fr)
PT (1) PT831820E (fr)
SI (1) SI0831820T1 (fr)
TW (1) TW460283B (fr)
WO (1) WO1996039139A1 (fr)
ZA (1) ZA964517B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0766668B1 (fr) * 1994-05-18 2002-07-17 Aventis Pharmaceuticals Inc. Procedes de preparation de formes anhydres et hydratees de derives de piperidine antihistaminiques, polymorphes et pseudomorphes de ces dernieres
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2213700C (fr) * 1995-02-28 2002-04-02 Hoechst Marion Roussel, Inc. Composition pharmaceutique pour composes de piperidinoalcanol
ES2107375B1 (es) * 1995-08-01 1998-07-01 Almirall Prodesfarma Sa Formulaciones farmaceuticas liquidas de ebastina por via oral.
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6613906B1 (en) * 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3966949A (en) * 1973-10-12 1976-06-29 Richardson-Merrell Inc. Pharmaceutical compositions and preparing same
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0111114A3 (fr) * 1982-11-06 1985-10-09 Telefonbau und Normalzeit GmbH Montage pour une centrale téléphonique, en particulier une centrale téléphonique privée avec communication additionnelle de données
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US4966061A (en) * 1989-03-27 1990-10-30 Riera John F Tube cutting apparatus

Also Published As

Publication number Publication date
HU227710B1 (en) 2011-12-28
AR002191A1 (es) 1998-01-07
IL118525A0 (en) 1996-10-16
ES2211954T3 (es) 2004-07-16
CA2218643A1 (fr) 1996-12-12
ATE256465T1 (de) 2004-01-15
NZ307370A (en) 1999-07-29
TW460283B (en) 2001-10-21
ZA964517B (en) 1996-12-09
CN1139386C (zh) 2004-02-25
JP4091655B2 (ja) 2008-05-28
HUP9802096A2 (hu) 1999-01-28
MX9709453A (es) 1998-02-28
CA2218643C (fr) 2001-12-11
NO318029B1 (no) 2005-01-24
HUP9802096A3 (en) 1999-06-28
PT831820E (pt) 2004-05-31
SI0831820T1 (en) 2004-04-30
DE69631132D1 (de) 2004-01-29
AU5669596A (en) 1996-12-24
AU707218B2 (en) 1999-07-08
EP0831820A1 (fr) 1998-04-01
WO1996039139A1 (fr) 1996-12-12
DE69631132T2 (de) 2004-08-19
NO975680L (no) 1998-02-05
EP0831820B1 (fr) 2003-12-17
KR100509316B1 (ko) 2005-11-25
CN1187125A (zh) 1998-07-08
NO975680D0 (no) 1997-12-05
US5574045A (en) 1996-11-12
IL118525A (en) 2001-07-24
KR19990022504A (ko) 1999-03-25
JPH11506115A (ja) 1999-06-02

Similar Documents

Publication Publication Date Title
ATE284695T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend 2-methyl-thienobenzodiazepin
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
NO20004345L (no) Farmasøytisk sammensetning
IS4706A (is) Lyfjasamsetningar
FI973518L (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
ATE260659T1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
FI910088A7 (fi) Oraalinen farmaseuttinen koostumus
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
DK0831820T3 (da) Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform
FI973229A7 (fi) Uusi farmaseuttinen koostumus
LV11727A (lv) Farmaceitiska kompozicija
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
FI973280A7 (fi) Farmaseuttinen koostumus
BR9606974A (pt) Composições orais
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
FI962979A7 (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
BR9605777A (pt) Composição farmacêutica
BR9605131A (pt) Composição farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402925D0 (sv) Novel oral pharmaceutical composition
SE9402924D0 (sv) Novel pharmaceutical composition